SID Medicos Reaches 200 Lemon Bottle Academies in the UK
The UK Academies form a major part of SID Medicos' global network of 330 Lemon Bottle Academies worldwide, which underscores the brand's commitment to advancing aesthetic practices globally.
Lemon Bottle Academies provides practitioners with CPD-accredited training on best practice for safely administering Lemon Bottle treatments to the highest standard. They offer specialised training programmes for skincare and fat-dissolving treatments, developed by independent, experienced practitioners to set a high standard in aesthetic practice.
Notably, most UK academies are led by female CEOs, creating opportunities for women to advance professionally, and demonstrating how the Lemon Bottle initiative goes beyond aesthetics to foster empowerment and leadership.
To ensure excellence, SID Medicos has established a clear pathway for aspiring academy owners:
Educational eligibility: Candidates must present a CPD badge confirming their qualification to offer fat-dissolving treatments in the UK.
Mastering the protocol: Completion of the Official Lemon Bottle Academy training to master the unique and safer Lemon Bottle protocols. 1 st generation academies are the original academies that were set up, providing specialist knowledge.
Course creation and certification: Candidates must develop a specific manual for the Lemon Bottle training program and obtain accreditation through SID Medicos-approved bodies, such as the CPD Group.
Over 1,500 individuals have enrolled in Lemon Bottle training courses globally, reflecting the high demand for these innovative solutions. This growing network of trained professionals ensures the consistent delivery of high-quality treatments worldwide.
Other practitioners can develop their knowledge, inspire others, and deliver exceptional results by enrolling in a Lemon Bottle course or starting their own academy.
Hong Sang Hyeon, Chief Executive Officer of SID Medicos, said: 'The continued growth of our network of Lemon Bottle Academies reflects the popularity of Lemon Bottle treatments among practitioners and patients. By training a new generation of practitioners, our academies are ensuring the highest standards of delivery for our treatments across the UK and globally, and providing opportunities for practitioners to advance their careers.'
About SID Medicos
SID Medicos is a South Korean company specialising in the distribution and supply of medical aesthetic products. It is the brand owner of Lemon Bottle, a Korean lipolysis and skin booster solution. Through continuous research and development in collaboration with plastic surgeons and dermatologists, SID Medicos aims to provide comprehensive aesthetic solutions. The company's commitment to high-quality products is evident in its strict manufacturing standards and the use of advanced technologies in the production processes.
Lemon Bottle carries the following region-specific cosmetic certifications:
1. CPNP : Europe
2. SCPN : UK
3. NMPA : China
4. PMDA : Japan
5. Health Canada : Canada
6. EAC : Russia
7. CCPN : Saudi Arabia
8. FDA MoCRA : USA
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
7 hours ago
- Business Wire
InnoCare Announces Approval of Clinical Trial of a Novel ADC ICP-B794 in China
BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today the approval of the Investigational New Drug (IND) by the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) to conduct the clinical trial of a novel B7-H3 targeted ADC ICP-B794. ICP-B794 is developed from InnoCare's proprietary ADC platform. The platform is designed to deliver ADCs with strong tumor-killing efficacy and an adequate therapeutic window, thereby broadening treatment options for cancer patients. Share ICP-B794 is a novel ADC comprising a humanized anti-B7-H3 monoclonal antibody conjugated to potent in-house developed payload via a protease-cleavable linker. This combination ensures precise targeting of tumor cells while minimizing off-target effects, offering a promising treatment for solid tumors such as lung cancer, esophageal cancer, nasopharyngeal cancer, head and neck squamous cell carcinomas, prostate cancer, and others. Currently, there are no B7-H3 targeted therapies approved for marketing globally. B7-H3 is a type I transmembrane protein that is highly expressed in a variety of solid tumors. Due to its specific expression in tumor cells, it is considered a highly promising anti-tumor target. Dr. Jasmine Cui, the Co-founder, Chairwoman, and CEO of InnoCare, said, "ICP-B794 is developed from the Company's proprietary ADC platform. The platform is designed to deliver ADCs with strong tumor-killing efficacy and an adequate therapeutic window, thereby broadening treatment options for cancer patients and improving their clinical outcomes. As the platform continues to evolve, the Company is poised to expand its portfolio with multiple differentiated ADC candidates, further advancing precision medicine in oncology." With ongoing efforts to address the growing needs in solid tumors, InnoCare is committed to building a competitive drug portfolio aimed at treating a broad range of solid tumor indications. The Company is expanding the scope of its pipeline through a combination of targeted therapies, immune-oncology approaches, and cutting-edge ADC technology. The R&D team is focused on discovering and developing novel platforms that target various solid tumors, utilizing innovative technologies to identify and advance potential drug candidates that offer significant clinical benefits. InnoCare's proprietary ADC technology platform, alongside promising precision medicine candidates like TRK inhibitor zurletrectinib (ICP-723), positions the Company to establish a strong presence in the field of solid tumor treatment. About InnoCare InnoCare is a commercial stage biopharmaceutical company committed to discovering, developing, and commercializing first-in-class and/or best-in-class drugs for the treatment of cancers and autoimmune diseases with unmet medical needs in China and worldwide. InnoCare has branches in Beijing, Nanjing, Shanghai, Guangzhou, Hong Kong, and the United States. InnoCare Forward-looking Statements This report contains the disclosure of some forward-looking statements. Except for statements of facts, all other statements can be regarded as forward-looking statements, that is, about our or our management's intentions, plans, beliefs, or expectations that will or may occur in the future. Such statements are assumptions and estimates made by our management based on its experience and knowledge of historical trends, current conditions, expected future development and other related factors. This forward-looking statement does not guarantee future performance, and actual results, development and business decisions may not match the expectations of the forward-looking statement. Our forward-looking statements are also subject to a large number of risks and uncertainties, which may affect our short-term and long-term performance.
Time Business News
8 hours ago
- Time Business News
Understanding Hair Transplant in Turkey Cost: What Patients Often Overlook
As Turkey cements its position as a global leader in medical tourism for hair restoration, prospective patients are increasingly attracted by the affordability of procedures. But beyond the compelling price tags lies a far more nuanced question: What truly determines the cost of a hair transplant in Turkey? For individuals seeking both results and reliability, understanding the hidden drivers of pricing is essential. If you're weighing options, evaluating the hair transplant in Turkey cost should go beyond simply scanning clinic brochures or blog lists. Instead, focus on the structural components that define quality and determine long-term satisfaction. Hair transplant procedures in Turkey typically range from $1,500 to $4,000, a stark contrast to Western prices. But what might appear as a simple pricing advantage often masks significant differences in technique, clinical expertise, graft quality, and post-care standards. Graft Quantity & Quality : Clinics often quote prices based on the number of grafts. But fewer high-quality grafts properly implanted can outperform bulk, poorly extracted ones. : Clinics often quote prices based on the number of grafts. But fewer high-quality grafts properly implanted can outperform bulk, poorly extracted ones. Surgeon Involvement : Is a certified surgeon performing the procedure, or just overseeing a technician-led team? This drastically changes the value proposition. : Is a certified surgeon performing the procedure, or just overseeing a technician-led team? This drastically changes the value proposition. FUE vs. DHI Technique : The cost varies between methods like Follicular Unit Extraction (FUE) and Direct Hair Implantation (DHI). DHI is typically more precise and thus, more expensive. : The cost varies between methods like Follicular Unit Extraction (FUE) and Direct Hair Implantation (DHI). DHI is typically more precise and thus, more expensive. Clinic Accreditation: JCI-accredited or MoH-certified clinics may charge more—but these credentials offer assurance in hygiene, safety, and protocol compliance. Many Turkish clinics offer all-inclusive packages covering transfers, accommodations, consultations, aftercare kits, and the surgery itself. While convenient, it's crucial to understand what is — and isn't — included. Patients should ask: Does the quoted hair transplant in Turkey cost include post-op checkups? include post-op checkups? Is anesthesia handled by a specialist? Are results guaranteed or followed up with revisions if needed? The most cost-effective transplant isn't always the cheapest one—it's the one that delivers lasting results without medical or financial surprises down the line. Clinics in Turkey can be segmented into three general tiers: Tier Price Range Traits Entry-Level $1,000–$1,800 Often rely heavily on technicians; limited customization. Mid-Tier $1,800–$2,800 Qualified surgeons with decent pre/post care, quality facilities. Premium $2,800–$4,500+ Surgeon-led procedures, advanced techniques, global accreditations. Neo Hair Transplant, for example, belongs to the category of clinics that prioritize long-term success and patient safety over high-volume turnover—justifying its placement within a transparent, value-driven pricing structure. What many patients fail to consider is the cost of revision surgeries after subpar procedures. Opting for bargain transplants often results in scarring, uneven growth, or even donor area depletion — all of which may demand corrective procedures costing double or triple the original rate. Investing once in a properly executed procedure by a reliable clinic can often be cheaper in the long run than opting for the cheapest offer today. Understanding the real cost of a hair transplant in Turkey means looking beyond the initial quote. When selecting a clinic, focus on the blend of: Medical credibility Transparent pricing Comprehensive pre- and post-care Realistic growth expectations Your choice of clinic and treatment isn't just a financial decision; it's a personal investment in your confidence and appearance. Be strategic—not just economical—with your approach. To explore more about what your investment entails and how transparent pricing works, visit Neo Hair Transplant's guide on hair transplant in Turkey cost. TIME BUSINESS NEWS
Business Wire
10 hours ago
- Business Wire
CORRECTING and REPLACING Vouched Developing Integration in Epic Toolbox Under Construction for Remote Identity Verification
SEATTLE--(BUSINESS WIRE)--Please replace the release dated June 10, 2025 with the following corrected version due to multiple revisions. The updated release reads: Vouched Developing Integration in Epic Toolbox Under Construction for Remote Identity Verification Integration Empowers Hospitals to Streamline Patient Onboarding, Enhance Compliance, and Improve Care Delivery with Seamless AI-Driven Identity Verification in Epic Vouched, the AI-powered identity verification platform trusted by leading healthcare systems, is now officially developing integration within Epic Toolbox Under Construction — bringing faster, safer patient onboarding, MyChart account creation and account recovery directly into Epic. This milestone enables hospitals and healthcare systems to seamlessly integrate VouchedRx, a customized identity verification solution for healthcare providers, powerful identity verification technology directly into their Epic electronic health record (EHR) systems—enhancing patient intake, compliance, and operational efficiency. As a trusted partner in healthcare, Vouched's AI-based platform automates and streamlines identity verification, reducing manual steps and administrative burdens. With its inclusion in Epic Toolbox Under Construction, healthcare providers will soon be able to slash patient intake times, minimize fraud risk, and speed access to care — while meeting the highest security and compliance standards. 'Being part of Epic Toolbox Under Construction is a strategic milestone in our mission to become an indispensable technology partner to hospitals and healthcare systems,' said Peter Horadan, CEO of Vouched. 'Our inclusion allows us to support healthcare organizations in modernizing how they verify patient identities—an essential step in reducing fraud, improving patient outcomes, and driving down costs.' Epic Toolbox Under Construction highlights products in specific categories that will become available once development is released by Epic and participating developers. The designation also signifies that the product adheres to Epic's recommended connection practices for a category, making it easier for health systems to adopt cutting-edge technologies without lengthy custom development cycles. By joining this ecosystem, Vouched furthers our commitment to empowering healthcare organizations to implement best-in-class ID verification natively within their clinical workflows. As digital transformation in healthcare accelerates, identity verification remains a critical first step in ensuring patient data integrity and delivering equitable, efficient care. With Vouched now part of Epic Toolbox Under Construction, providers will soon gain access to a seamless and scalable solution for verifying identities across diverse patient populations, including telehealth, urgent care, and in-person settings. Epic and MyChart are registered trademarks of Epic Systems Corporation. About Vouched Vouched is a leading AI-powered identity verification platform serving industries with high-stakes verification needs like healthcare, finance, and automotive. Trusted by enterprises around the world, Vouched verifies millions of identities annually with speed, accuracy, and compliance. To learn more, visit
